Extracorporeal CO2 Removal Devices Market Size (2024 - 2029)

Extracorporeal CO2 Removal Devices Market Analysis

The Extracorporeal CO2 Removal Devices Market size is estimated at USD 195.5 million in 2024, and is expected to reach USD 274.80 million by 2029, growing at a CAGR of 7.10% during the forecast period (2024-2029).

The COVID-19 pandemic impacted the growth of the extracorporeal CO2 removal devices market. For instance, as per the research study published in the Lancet Respiratory Medicine in April 2021, the risk of severe COVID-19 in people with asthma is relatively small, but people with COPD and interstitial lung disease appear to have a modestly increased risk of severe disease due to COVID-19. Thus, the pandemic impacted market growth. However, with removed restrictions and trade barriers, the supply chain of ECMO machines has increased, which is expected to fuel the market growth over the forecast period.

Factors such as the increasing prevalence of COPD and other respiratory diseases, as well as the rising number of product launches and approvals, are expected to boost the market growth over the forecast period.

The increasing prevalence of chronic obstructive pulmonary diseases (COPD) and other diseases is the key factor driving the market growth. For instance, according to the study published in the PLOS ONE journal in January 2021, in France, about 2.6 million people were suffering from COPD. By 2025, that number is expected to rise to 2.8 million. Additionally, according to 2022 statistics published by National Health Science, about 1.17 million people in England were diagnosed with COPD in 2020-21, accounting for 1.9% of the total population. Thus, the high burden of COPD among the population raises the demand for extracorporeal CO2 removal devices for vitalizing blood flow and efficient gas exchange, hence propelling the market growth.

Furthermore, the growing company activities and the growing number of product launches, as well as product approvals, increase the availability of CO2 removal devices in the market, which in turn is anticipated to fuel the market growth. For instance, in November 2021, ALung Technologies received the FDA's de novo clearance for its Hemolung respiratory assist system, the first extracorporeal carbon dioxide removal device.

New technologies are enhancing the number of potential applications for the ECMO technology in useful ways, including new-patient population and the ability to make the ECMO technology mobile for both intra- and inter-hospital transport. For the equipment available for short- and long-term ECMO applications, significant technical advancements have been observed. Modern ECMO systems that have enhanced biocompatibility are miniaturized and portable, and they render the provision of this technique in a simpler and safer way.

Therefore, owing to factors such as the high burden of COPD and other respiratory disorders as well as growing product approvals, the studied market is anticipated to grow over the forecast period. However, the risks of complications during extracorporeal CO2 removal therapy are likely to hinder the growth of the extracorporeal CO2 removal devices market over the forecast period.

Extracorporeal CO2 Removal Devices Industry Segmentation

As per the scope, extracorporeal carbon dioxide removal (ECCO2R) is a different approach to artificial gas exchange. Extracorporeal carbon dioxide removal is the removal of carbon dioxide from the bloodstream in people who have elevated levels of carbon dioxide as a result of respiratory failure. 

The Extracorporeal CO2 Removal Devices Market is Segmented by Product (Extracorporeal CO2 Devices, Disposables, and Other Products), Application (Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS), Bridge to Lung Transplant, and Other Applications), End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the market size in value terms in USD for all the abovementioned segments.